← Back to news

Markets

This Quantum Computing Stock Just Got an Outperform Rating. It’s the Only Public Neutral Atom Company.

Y

Oil Prices Head for Biggest Quarterly Drop Since Pandemic

Y

Stock Indexes Supported by Strong Demand for Technology Stocks

Y

Q2 US Leveraged Finance Survey: Software, inflation remain in the crosshairs

Y

Madison Mid Cap Fund Added Moelis & Company (MC) on a Dip

Y

Quantum Computing Just Hit Commercial Viability and Trump’s $2 Billion Quantum Push Has These 3 ETFs Sitting on Top of the Trade

Y

Chinalco Mining to acquire 95% stake in Opuwo Project

Y

Dubai Braces For Crypto Influx As European Rules Come Into Force

Y

The first half of 2026 was a roller coaster. It's time to check on how your finances withstood the ride.

Y

This 7% Yielding Healthcare Powerhouse Belongs in Retirees’ Portfolios

Y

Rising Oil Prices and Interest Rates Hurt Thor Industries (THO) in Q1

Y

The Dividend ETF That Belongs in Almost Every Long-Term Portfolio

Y

Could This New Chip Be a Game Changer for Broadcom Stock?

Y

Goldman downgraded, Block upgraded: Wall Street's top analyst calls

Y

3 Resilient Defense Stocks to Buy Now

Y

Madison Mid Cap Fund Bets on Bentley Systems (BSY) for Years of Growth Ahead

Y

Equinor to transfer Peon interest to Vår Energi in NCS deal

Y

4 Reasons BTIG Is Buying Robinhood Stock Right Now

Y

Palantir stock has crashed this year, but there may be upside ahead

Y

Do You Believe in the Long-Term Earnings Potential of Formula One Group (FWONK)?

Y

Does Tyler Technologies (TYL) Have a Long Runway for Sales Growth?

Y

NVIDIA (NVDA), Palantir (PLTR) Partner to Deploy Secure AI Models for Government and Infrastructure

Y

Palantir (PLTR), Surf Air Mobility Expand Partnership to Accelerate SurfOS Platform Development

Y

Adobe (ADBE) Launches Firefly Foundry to Enable Enterprise Custom AI Model Development

Y

CoreWeave (CRWV) Expands European AI Infrastructure Through New Partnership with Conapto

Y

International Business Machines (IBM) Unveils World’s First 0.7-Nanometer Semiconductor Tech

Y

Is Baidu (BIDU) One of the AI Stocks on Wall Street’s Radar?

Y

Digital Realty (DLR) Launches ServiceFabric MCP for AI-Native Infrastructure Control

Y

Here is Why SentinelOne (S) is One of the AI Stocks on Wall Street’s Radar

Y

Check Point (CHKP) Integrates OpenAI Frontier Models into Security Suite

Y

Cerebras Systems (CBRS): 10 AI Stocks on Wall Street’s Radar

Y

Is ServiceTitan (TTAN) Unfairly Punished Beyond Fundamentals?

Y

Italy’s La Doria buys B2B tomato supplier Solana

Y

Brown & Brown (BRO) Dropped on Softness in Organic Growth

Y

Silver Just Hit A 'Now Or Never' Level: Which Miner Is Best Positioned If The Metal Bounces?

Y

Apple Price Hikes Sent AAPL Stock Falling. They May Not Even Matter in the Long Term.

Y

Securitize Lists on NYSE as SECZ: Backed by $400M Raise and BlackRock BUIDL

Y

Cathie Wood Makes Fresh Bullish Bitcoin Call — Just Months After $1.5M Prediction

Y

Wall Street Futures Edge Lower as Investors Lock In Profits After Record Rally: Dow Jones, S&P, Nasdaq

Y

XRPL Lending Protocol Testing Opens as Validator Vote on XLS-65 and XLS-66 Continues

Y

The John Rogers Contrarian Playbook: How Envista, MSG Entertainment, and Smucker Stack Up for Retirement Investors

Y

Where Will Tesla Stock Be in 5 Years?

Y

Is MapLight Therapeutics, Inc. (MPLT) Stock a Biotech Opportunity Ahead of the ZEPHYR Trial Readout?

Y

Is Rhythm Pharmaceuticals, Inc. (RYTM) Stock Poised for Growth After Encouraging Setmelanotide Trial Results?

Y

MoonLake Immunotherapeutics (MLTX) Outlook Strengthens as Analysts See Major Opportunity in Hidradenitis Suppurativa

Y

Is Definium Therapeutics, Inc. (DFTX) Stock Poised for Further Gains After Positive Emerge Trial Update?

Y

Is Zymeworks Inc. (ZYME) Stock an Undervalued Biotech Opportunity With Oncology Growth Ahead?

Y

Is Celldex Therapeutics, Inc. (CLDX) Stock Positioned for Growth Ahead of Potential 2027 Approval?

Y

Nurix Therapeutics, Inc. (NRIX) Price Target Raised to $33 on Roche Partnership Value

Y

Is Jade Biosciences, Inc. (JBIO) Stock a Rising Biotech Opportunity in the $20B IgA Nephropathy Market?

Y